IPP Bureau
Indoco’s AnaCipher receives UK-MHRA accreditation
By IPP Bureau - August 27, 2021
The clinical research organisation located in Hyderabad is a USFDA inspected facility
Brazil’s Eurofarma to manufacture Comirnaty for Latin America
By IPP Bureau - August 27, 2021
The manufacture of finished doses will commence in 2022 and at full operational capacity, the annual production is expected to exceed 100 million doses annually
Pharma continues to attract PE investments: Care Ratings
By IPP Bureau - August 27, 2021
In H1FY21, it attracted PE deals worth US $ 1.6 billion compared to US $ 3 billion in CY2020
Johnson & Johnson booster dose indicate impressive results
By IPP Bureau - August 26, 2021
New interim data from these studies demonstrate that a booster dose of the Johnson & Johnson Covid-19 vaccine generated a rapid and robust increase in spike-binding antibodies, nine-fold higher than 28 days after the primary single-dose vaccination.
Pfizer and BioNTech initiate rolling submission for Comirnaty booster dose
By IPP Bureau - August 26, 2021
The submission to the US FDA has been initiated and they intend to file these data with the European Medicines Agency and other regulatory bodies in the coming weeks
Doctors at MGM Healthcare perform complex bilateral lung transplant
By IPP Bureau - August 26, 2021
The boy becomes India’s youngest recipient to undergo bilateral lung transplantation.
Adjuvance announce clinical results of its next-gen saponin adjuvant
By IPP Bureau - August 26, 2021
First results demonstrate favourable tolerability of TQL-1055 at all dose levels
Wockhardt and Jemincare partner for novel respiratory antibiotic Nafithromycin
By IPP Bureau - August 26, 2021
The company to receive upfront and milestone payments, in addition to royalties
Merck donates Rs 1.7 crore to IIT Bombay for Covid-19 research
By IPP Bureau - August 26, 2021
The two-year donation supports the development of clinical tests for Covid-19 severity assessment and the focus on the development of simple immunoassays using single molecule counting technology
Sai Life Sciences is now a United Nations Global Compact (UNGC) signatory
By IPP Bureau - August 26, 2021
In the last two years, Sai Life Sciences has made significant investments and progress in advancing its sustainability agenda as part of its organizational transformation initiative
RedHill Biopharma's Opaganib demonstrates strong inhibition of COVID-19 Delta variant
By IPP Bureau - August 26, 2021
Opaganib, a leading novel small molecule investigational oral pill in development for Covid-19, is a unique host targeted, dual antiviral and anti-inflammatory drug that acts on the cause and effect of the disease
Strong show in domestic formulations business by Indian pharma in Q1FY22: Ind-Ra
By IPP Bureau - August 26, 2021
Domestic business was up 41.9% YoY and 27.7% QoQ
Pune-based Jehangir Hospital records 500 kidney transplants
By IPP Bureau - August 25, 2021
The hospital works in close collaboration with the Network for Organ Sharing and the National Organ & Tissue Transplant Organisation (NOTTO) and it is amongst the very few hospitals doing ABO-incompatible transplant
US FDA approves Medtronic’s TAVR System
By IPP Bureau - August 25, 2021
The Evolut FX TAVR system is used for treatment of symptomatic severe aortic stenosis and it has features that enhance ease-of-use and predictable valve deployment
Regimen launches world’s first personalised digital therapy for ED
By IPP Bureau - August 25, 2021
The company recently raised US $ 2.25 million seed round and the app was CE-Certified as a medical device in Europe
